Retatrutide
Retatrutide is a next-generation triple agonist peptide studied for its activation of the GLP-1, GIP, and glucagon receptors. By targeting three key metabolic pathways at once, it has become a major focus in modern metabolic and body-composition research.
Its triple-receptor profile is widely explored in laboratory models related to energy balance, fat metabolism, and glucose regulation.
Each vial contains high-purity, lyophilized Retatrutide intended for controlled laboratory applications.
For in vitro research use only. Not for human or veterinary use.